Yuan-Ming Hsu

449 citations
10 papers · 354 indexed · h-index 6
Topics
Cancer-related molecular mechanisms research (4 papers)MicroRNA in disease regulation (3 papers)Knee injuries and reconstruction techniques (2 papers)
Partner nations
TaiwanSwitzerlandRussia

In The Last Decade

Yuan-Ming Hsu

10 papers receiving 347 citations

Peers

Yuan-Ming Hsu
Comparison fields: 5 of 77
  • Molecular Biology 227
  • Cancer Research 104
  • Surgery 53
  • Oncology 37
  • Biomedical Engineering 35
Replace Duenpim Parisuthiman with:
Duenpim Parisuthiman United States
Je‐Yong Choi South Korea
Shiuhyang Kuo United States
Xuanping Huang China
Harsh Dongre Norway
Eva Švandová Czechia
Xueyang Liao China
Fulan Wei China
Meysam Ganjibakhsh Iran
Yuan-Ming Hsu relative to Duenpim Parisuthiman United States Duenpim Parisuthiman's profile →
Citations per field
00.5×2.9×
Duenpim Parisuthiman · 1×
Citations per year

Countries citing papers authored by Yuan-Ming Hsu

Since Specialization
Citations

This map shows the geographic impact of Yuan-Ming Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuan-Ming Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuan-Ming Hsu more than expected).

Fields of papers citing papers by Yuan-Ming Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuan-Ming Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuan-Ming Hsu. The network helps show where Yuan-Ming Hsu may publish in the future.

Co-authorship network of co-authors of Yuan-Ming Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Yuan-Ming Hsu. A scholar is included among the top collaborators of Yuan-Ming Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuan-Ming Hsu. Yuan-Ming Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 4
2 2
3 6
4 23
5 115
6 1
7 2
8 96
9 42
10 63

About Yuan-Ming Hsu

Yuan-Ming Hsu is a scholar working on Cancer Research, Immunology and Allergy and Urology, having authored 10 papers that have together received 354 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (4 papers), MicroRNA in disease regulation (3 papers) and Knee injuries and reconstruction techniques (2 papers). The work is most often cited by research in Cancer Research (104 citations), Urology (25 citations) and Molecular Biology (227 citations). Yuan-Ming Hsu has collaborated with scholars based in Taiwan, Switzerland and Russia. Frequent co-authors include Lili Chen, Jinn‐Shiun Chen, Tze‐Sing Huang, Chia‐Chi Chen, Shine‐Gwo Shiah, Ann‐Joy Cheng, I–Shou Chang, Tung‐Yiu Wong, Shih‐Hsin Chang and Jang‐Yang Chang. Their work appears in journals such as Journal of Biological Chemistry, Cancer Research and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026